Work

A combination of histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC and AML cells with constitutively active mutant FLT-3 tyrosine kinase

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.6541

Authors: K. N. Bhalla, P. George, R. Gutti, P. Bali, J. Tao, F. Guo, C. Sigua, Y. Li, P. Cohen, P. Atadja

Institution: Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2565955886

Cites:

Cited by: 4

Related to: 10